FUROSEMIDE

Product NDC: 51662-1227
11-digit product format: 516621227
Labeler code: 51662
Product ID: 51662-1227_1031ee8d-58d0-6149-e063-6294a90a4f58
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: FUROSEMIDE
Dosage form: INJECTION, SOLUTION
Route: INTRAMUSCULAR; INTRAVENOUS
Labeler: HF Acquisition Co LLC, DBA HealthFirst
Application: NDA018667
Marketing category: NDA
Marketing start: 2018-09-14
Substance: FUROSEMIDE
Active strength: 10 mg/mL
Pharmacologic classes: Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N018667-001	FUROSEMIDE	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP		1982-05-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N018667-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`f41ea6bd6efb…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N018667-001	AP	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N018667-001	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018667-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018667-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018667-001	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018667-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018667-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018667-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018667-001	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018667-001	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018667-001	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N018667-001	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018667-001	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018667-001	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018667-001	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N018667-001	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018667-001	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N018667-001	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N018667-001	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018667-001	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N018667-001	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N018667-001	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018667-001	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N018667-001	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N018667-001	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N018667-001	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N018667-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N018667-001	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N018667-001	AP	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N018667-001	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N018667-001	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N018667-001	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N018667-001	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N018667-001	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N018667-001	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N018667-001	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N018667-001	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N018667-001	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N018667-001	AP	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N018667-001	AP	1	`f41ea6bd6efb…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: FUROSEMIDE
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
FUROSEMIDE	10 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7LXU5N7ZO5	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1719290	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
75d68f19-424c-109e-e053-2991aa0ac857	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d80d3aff-3a63-4d7b-a2be-fd9388b04330	Product name	9	20250806
9061e89f-9c86-4196-b34b-886fc1673cc4	Product name	1	20140821

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51662-1227-1	2020-02-07	C162847	48780-1	9d75b9d0-bc05-f424-e053-dadaa90a57ce	FUROSEMIDE INJ., USP 20mg/2mL (10mg/mL) VIAL
51662-1227-1	2020-01-31	C162847	48780-1	9d75b9d0-bc05-f424-e053-dadaa90a57ce	FUROSEMIDE INJ., USP 20mg/2mL (10mg/mL) VIAL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
51662-1227-1	FUROSEMIDE	2 mL in 1 VIAL, SINGLE-USE	INJECTION, SOLUTION	2	7
51662-1227-2	FUROSEMIDE	1 mL in 1 POUCH	INJECTION, SOLUTION	1	7
51662-1227-3	FUROSEMIDE	25 in 1 CASE	INJECTION, SOLUTION	25	7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51662-1227	FUROSEMIDE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST]	7	Current NDC, Legacy NDC, 3 package rows	20240131_75d68f19-424c-109e-e053-2991aa0ac857.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Furosemide	FUROSEMIDE	Medical Purchasing Solutions, LLC	58cc1e38-6000-1489-e063-6394a90a5978	2026-08-11	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
FUROSEMIDE	FUROSEMIDE	HF Acquisition Co LLC, DBA HealthFirst	75d5611a-f9e0-1841-e053-2991aa0af415	2026-06-23	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
Furosemide	FUROSEMIDE	Cardinal Health 107, LLC	71b48f4d-9936-448c-9e3a-33f1182e1039	2026-05-15	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
Furosemide	FUROSEMIDE	Hospira, Inc.	39fd32f2-6bb7-4a65-d298-e48d26bc80c7	2026-05-13	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
FUROSEMIDE	FUROSEMIDE	Hospira, Inc.	aaced7a8-c3d7-4d66-8c07-aa407b8b3f35	2026-05-13	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
Furosemide	FUROSEMIDE	Cardinal Health 107, LLC	8e0bac29-5a8b-4d4e-93b3-2e21eb3b0650	2026-05-06	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
FUROSEMIDE	FUROSEMIDE	HF Acquisition Co LLC, DBA HealthFirst	75d68f19-424c-109e-e053-2991aa0ac857	2024-01-30	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667 ndc (product): 51662-1227
FUROSEMIDE	FUROSEMIDE	HF Acquisition Co LLC, DBA HealthFirst	7b9af6a4-e1da-eb95-e053-2991aa0a031d	2024-01-22	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7LXU5N7ZO5	FUROSEMIDE	54-31-9	FUROSEMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1719290	furosemide 20 MG in 2 ML Injection	PSN	75d68f19-424c-109e-e053-2991aa0ac857	7
1719290	2 ML furosemide 10 MG/ML Injection	SCD	75d68f19-424c-109e-e053-2991aa0ac857	7
1719290	furosemide 20 MG per 2 ML Injection	SY	75d68f19-424c-109e-e053-2991aa0ac857	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
51662-1227-1	51662122701	2 mL in 1 VIAL, SINGLE-USE (51662-1227-1)	2 ml	2018-09-14	0000-00-00	No	No	Current
51662-1227-2	51662122702	1 mL in 1 POUCH	1 ml					Historical
51662-1227-3	51662122703	25 POUCH in 1 CASE (51662-1227-3) / 1 mL in 1 POUCH (51662-1227-2)	25 pouch	2020-10-27	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
FUROSEMIDE INJ., USP 20mg/2mL (10mg/mL) VIAL	HF Acquisition Co LLC, DBA HealthFirst	2024-01-30	HUMAN PRESCRIPTION DRUG LABEL	7